Biolinerx Ltd ADR (BLRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
Sales | 5,393 | 6,855 | 0 | 0 | 0 |
Cost of Goods | 897 | 1,455 | N/A | N/A | N/A |
Gross Profit | 4,496 | 5,400 | N/A | N/A | N/A |
Operating Expenses | 11,166 | 10,677 | 23,366 | 12,357 | 9,915 |
Operating Income | -5,773 | -4,822 | -18,566 | -12,357 | -9,915 |
Interest Expense | 2,085 | 929 | -932 | 837 | 1,337 |
Other Income | 8,342 | 5,055 | 3,750 | -2,829 | -7,293 |
Pre-tax Income | 484 | -696 | -13,884 | -16,023 | -18,545 |
Net Income Continuous | 484 | -696 | -13,884 | -16,023 | -18,545 |
Net Income | $484 | $-696 | $-13,884 | $-16,023 | $-18,545 |
EPS Basic Total Ops | 0.00 | 0.00 | -0.15 | -0.30 | -0.30 |
EPS Basic Continuous Ops | 0.01 | -0.01 | -0.19 | -0.26 | -0.30 |
EPS Diluted Total Ops | 0.00 | 0.00 | -0.15 | -0.30 | -0.30 |
EPS Diluted Continuous Ops | 0.01 | -0.01 | -0.19 | -0.26 | -0.30 |
EPS Diluted Before Non-Recurring Items | 0.01 | -0.01 | -0.15 | -0.30 | -0.30 |
EBITDA(a) | $-5,297 | $-3,925 | $-22,660 | $-12,136 | $-9,717 |